NIH will study Gilead's remdesivir-like compound against Covid-19

NIH will study Gilead's remdesivir-like compound against Covid-19

Urged on by scientists, NIH will study Gilead’s remdesivir-like compound against Covid-19

By ED SILVERMAN

YICHUAN CAO/SIPA USA

The NIH plans to independently explore whether a Gilead compound — which some academics say is highly similar to remdesivir — might combat Covid-19.

READ MORE